Development and evaluation of iManage: A self‐management app co‐designed by adolescents with sickle cell disease

Adolescents and young adults (AYAs) with sickle cell disease (SCD) are a vulnerable population with high risk of morbidity that could be decreased with effective self‐management. Previous research suggests that mobile applications (apps) may facilitate AYA engagement in health‐promoting behaviors. The objectives of this study were: (i) describe Internet access and use in AYA with SCD; (ii) identify barriers for self‐management in this population; (iii) collaborate with AYA to co‐design a mobile app that would minimize barriers; and (iv) evaluate the feasibility and acceptability of the app.

[1]  Aaron Smith,et al.  Social Media & Mobile Internet Use among Teens and Young Adults. Millennials. , 2010 .

[2]  M. Mitchell,et al.  Integrating Interactive Web-Based Technology to Assess Adherence and Clinical Outcomes in Pediatric Sickle Cell Disease , 2012, Anemia.

[3]  M. Gladwin,et al.  A pilot study of electronic directly observed therapy to improve hydroxyurea adherence in pediatric patients with sickle‐cell disease , 2014, Pediatric blood & cancer.

[4]  A. Giardino,et al.  Healthcare utilization and expenditures for low income children with sickle cell disease , 2009, Pediatric blood & cancer.

[5]  K. Hassell.  Population estimates of sickle cell disease in the U.S. , 2010, American journal of preventive medicine.

[6]  James R. Lewis,et al.  IBM computer usability satisfaction questionnaires: Psychometric evaluation and instructions for use , 1995, Int. J. Hum. Comput. Interact..

[7]  A. Lenhart.  Teens, Social Media & Technology Overview 2015 , 2015 .

[8]  J. Fowles,et al.  When activation changes, what else changes? the relationship between change in patient activation measure (PAM) and employees' health status and health behaviors. , 2012, Patient education and counseling.

[9]  Pamela L Owens,et al.  Acute care utilization and rehospitalizations for sickle cell disease. , 2010, JAMA.

[10]  R. Ware,et al.  Hydroxyurea for children with sickle cell disease. , 2010, Hematology/oncology clinics of North America.

[11]  K. Abrahamson,et al.  Self-efficacy, transition, and patient outcomes in the sickle cell disease population. , 2015, Pain management nursing : official journal of the American Society of Pain Management Nurses.

[12]  S. Badawy,et al.  Technology Access and Smartphone App Preferences for Medication Adherence in Adolescents and Young Adults With Sickle Cell Disease , 2016, Pediatric blood & cancer.

[13]  J. Schatz,et al.  Feasibility of Home‐Based Computerized Working Memory Training With Children and Adolescents With Sickle Cell Disease , 2016, Pediatric blood & cancer.

[14]  C. Quinn,et al.  A Biopsychosocial Model for the Management of Patients With Sickle-Cell Disease Transitioning to Adult Medical Care , 2015, Advances in Therapy.

[15]  J. Hibbard,et al.  Why Does Patient Activation Matter? An Examination of the Relationships Between Patient Activation and Health-Related Outcomes , 2012, Journal of General Internal Medicine.

[16]  J. Kramer,et al.  Cognitive functioning in children with sickle cell disease: a meta-analysis. , 2002, Journal of pediatric psychology.

[17]  G. Malham,et al.  Clinical Outcome and Fusion Rates after the First 30 Extreme Lateral Interbody Fusions , 2012, TheScientificWorldJournal.

[18]  D. Drotar,et al.  Pediatric Self-management: A Framework for Research, Practice, and Policy , 2012, Pediatrics.

[19]  Michael Greatorex,et al.  Statistical Package for the Social Sciences , 2015 .

[20]  Stephen Rollnick,et al.  Motivational Interviewing: Preparing People for Change, 2nd Edition , 2002 .

[21]  S. Ofori-Acquah,et al.  Spatiotemporal Dysfunction of the Vascular Permeability Barrier in Transgenic Mice with Sickle Cell Disease , 2012, Anemia.

[22]  Lori E Crosby,et al.  Perceived Barriers to Clinic Appointments for Adolescents With Sickle Cell Disease , 2009, Journal of pediatric hematology/oncology.

[23]  M. Goldberg,et al.  Beyond the Definitions of the Phenotypic Complications of Sickle Cell Disease: An Update on Management , 2012, TheScientificWorldJournal.

[24]  Tim Brown,et al.  Change by Design: How Design Thinking Transforms Organizations and Inspires Innovation , 2009 .

[25]  Carolyn Moxley Rouse,et al.  Uncertain Suffering: Racial Health Care Disparities and Sickle Cell Disease , 2009 .

[26]  Ingrid Mur-Veeman,et al.  Bringing user experience to healthcare improvement: the concepts, methods and practices of experience-based design , 2008, International Journal of Integrated Care.

[27]  M. Rapoff.  Definitions of Adherence, Types of Adherence Problems, and Adherence Rates , 2010 .

[28]  S. Dabbo,et al.  Motivational Interviewing: Preparing People to Change Addictive Behavior , 1993 .

[29]  C. Quinn,et al.  Improved survival of children and adolescents with sickle cell disease. , 2008, Blood.

[30]  L. Benjamin,et al.  Definitions of the phenotypic manifestations of sickle cell disease , 2009, American journal of hematology.

[31]  S. Howard,et al.  Improved hydroxyurea effect with the use of text messaging in children with sickle cell anemia , 2014, Pediatric blood & cancer.

[32]  Winfred C. Wang.  The pathophysiology, prevention, and treatment of stroke in sickle cell disease , 2007, Current opinion in hematology.

[33]  L. Callister,et al.  Patient‐centered care and adherence: Definitions and applications to improve outcomes , 2008, Journal of the American Academy of Nurse Practitioners.

[34]  N. Shah,et al.  Patients Welcome the Sickle Cell Disease Mobile Application to Record Symptoms via Technology (SMART) , 2014, Hemoglobin.